People presenting with persistent symptoms after acute SARS-CoV-2 infection commonly describe a fluctuating constellation of physical, cognitive, and emotional complaints. Core features of long covid include profound fatigue that is often disproportionate to exertion, post-exertional symptom exacerbation, shortness of breath, chest discomfort, palpitations, and varied neurological complaints such as headaches, dizziness, paresthesias, weakness, and tremor. Many individuals report “brain fog,” characterized by slowed thinking, difficulty concentrating, word-finding problems, forgetfulness, and impaired multitasking. Sleep disturbance, sensory hypersensitivity to light and sound, and heightened startle responses are also frequently described. Symptoms may shift from day to day or even hour to hour, creating a sense of unpredictability that adds to distress and functional impairment.
These clinical features overlap substantially with functional neurological symptoms, where physical and cognitive symptoms are genuine and disabling but are not fully explained by structural damage or a primary neurodegenerative process. Functional neurological presentations can include limb weakness, non-epileptic attacks, gait disturbance, tremor, abnormal movements, speech disturbance, visual symptoms, and sensory loss. In both long covid and functional disorders, the pattern of symptoms often fits poorly with classical neurological disease: symptoms can be internally inconsistent, triggered or worsened by attention or stress, and partially improved by distraction or dual-tasking. Patients may describe episodes where legs feel “like jelly” or suddenly give way, spells of unresponsiveness with preserved awareness, or variable slurring of speech that improves when they are engaged in a different task.
Cognitive symptoms in long covid and functional presentations often show a similar pattern. Individuals may experience significant perceived cognitive failure in everyday life—such as forgetting recent conversations, losing track of tasks, or struggling to follow complex instructions—while formal neuropsychological assessment reveals only mild deficits or a patchy profile that does not conform to typical patterns of structural brain injury. Performance can fluctuate markedly across tasks and over time, with strong effects of fatigue, anxiety, and task threat. This mismatch between the severity of reported “brain fog” and relatively modest objective findings can be misinterpreted as exaggeration, but in both conditions it more accurately reflects the role of altered attention, heightened symptom monitoring, and disrupted cognitive efficiency.
Autonomic complaints provide another area of overlap. People with long covid frequently describe manifestations of dysautonomia, such as orthostatic intolerance, tachycardia on standing, temperature dysregulation, gastrointestinal disturbance, and episodes of sweating, flushing, or feeling “about to faint.” Similar autonomic symptom clusters are well recognized in functional disorders and often co-occur with chronic fatigue, pain syndromes, and functional neurological manifestations. In both scenarios, autonomic testing may show mild abnormalities or be entirely normal, and symptoms are typically influenced by posture, emotional arousal, and environmental triggers. The subjective experience of bodily instability and internal “overdrive” can be intense, reinforcing hypervigilance to internal sensations.
Pain is highly prevalent across these presentations. In long covid, patients may report diffuse myalgia, joint pain without clear inflammatory findings, chest wall pain, headaches, and neuropathic-like sensations such as burning, tingling, or electric shock-like pains. Functional neurological symptom disorders are also commonly accompanied by chronic pain, including functional limb pain, non-cardiac chest pain, and headaches that lack a clear structural cause. Pain can create a feedback loop: heightened focus on bodily discomfort increases pain perception and fuels anxiety, which in turn amplifies other symptoms such as fatigue and sleep disturbance. This multidimensional pain profile blurs traditional boundaries between “neurological,” “musculoskeletal,” and “psychological” complaints.
Motor and sensory symptoms in long covid can resemble those seen in functional neurological disorders. Some patients report episodic limb weakness, feelings of heaviness, or difficulty initiating movements, despite normal strength on examination between episodes. Others describe transient numbness, tingling, or patchy sensory changes that migrate or do not follow anatomical distributions. When carefully examined, clinicians may observe features such as inconsistent weakness, collapsing or “give-way” strength, Hoover’s sign, or tremor that varies with distraction—hallmarks of functional motor symptoms. Yet these patients have a clear temporal association with a viral illness, and some may also have evidence of low-level inflammation, autonomic changes, or small-fiber neuropathy, demonstrating how organic and functional mechanisms can coexist in the same individual.
Mood and anxiety symptoms commonly accompany both long covid and functional neurological presentations, but they vary widely in severity and timing. Some individuals have pre-existing anxiety, depression, or trauma histories that may lower resilience to the stress of acute illness and prolonged recovery. Others develop mood symptoms secondarily as they grapple with loss of function, uncertainty about prognosis, financial strain, and disrupted social roles. In both conditions, hypervigilance to bodily sensations, catastrophic interpretations of minor fluctuations, and repeated checking behaviors can drive symptom amplification. However, significant numbers of patients describe disabling symptoms in the absence of major mood disturbance, underscoring that psychological factors modulate but do not fully explain their experience.
The temporal pattern of symptom onset offers further parallels. Long covid typically emerges after a recognizable viral infection, but for many patients the initial illness may be relatively mild. Symptoms can persist beyond 12 weeks, sometimes after a brief “recovery” phase, and may be triggered by physical exertion, cognitive load, or emotional stress. Functional neurological symptoms likewise often follow identifiable stressors or physical events, such as minor injuries, infections, surgical procedures, or episodes of acute emotional distress. In both cases, the precipitating event serves as a catalyst that interacts with individual vulnerability factors—past health experiences, beliefs about illness, coping styles, and social context—to shape the trajectory of symptoms.
From a functional standpoint, the overlap between long covid and functional symptomatology is evident in the impact on daily life. Many individuals experience substantial limitation in work capacity, caregiving, and social engagement. Tasks that were previously automatic—climbing stairs, preparing meals, concentrating on a meeting—may now require careful pacing and rest breaks. Some people become largely housebound, while others can maintain outwardly normal routines at the cost of severe symptom exacerbation afterwards. This pattern of pushing to meet obligations followed by prolonged “crashes” resonates with experiences reported in chronic fatigue states and functional disorders, reflecting shared challenges around activity management, energy conservation, and the balance between rest and engagement.
The clinical overlap can complicate communication between patient and clinician. Individuals with long covid may reject any suggestion that their symptoms could have a functional component, fearing this implies that their condition is “imagined” or “not real.” Conversely, patients with longstanding functional neurological symptoms may feel that their experience is only validated when framed in terms of infection or inflammation. Terminology such as “functional,” “psychological,” or “medically unexplained” can carry heavy stigma and may undermine trust if not handled carefully. The reality for many people is a hybrid picture in which biological changes related to infection coexist with changes in nervous system function, attention, and behavior typically seen in functional disorders.
During clinical assessment, these overlaps mean that a strictly dichotomous approach—labeling symptoms as either long covid or functional—often fails to capture the complexity of the presentation. Instead, clinicians benefit from characterizing the full range of symptoms, triggering and relieving factors, patterns of inconsistency, and the person’s explanatory models. Recognizing features suggestive of functional neurological symptoms does not negate the impact of the original infection; rather, it broadens the framework for understanding why symptoms have persisted or evolved. Identifying shared features across these conditions can help guide targeted interventions—such as paced activity, cognitive strategies for managing brain fog, treatment of dysautonomia, and psychologically informed rehabilitation—while avoiding premature dismissal of the patient’s lived experience.
Proposed mechanisms linking infection, stress, and neurobiology
Multiple, interacting mechanisms appear to link SARS-CoV-2 infection, psychological stress, and altered neurobiology in ways that can sustain symptoms long after the acute illness. Rather than a single linear pathway, evidence points to overlapping processes involving immune activation, autonomic dysregulation, neuroendocrine changes, altered interoception, and learning within brain networks that regulate attention, emotion, and movement. These mechanisms can help explain why individuals with similar acute infections follow very different trajectories, and why a subset develop a pattern of persistent symptoms that resembles both long covid and functional neurological disorders.
Persistent immune activation is a central candidate mechanism. In some people, SARS-CoV-2 infection triggers an exaggerated or prolonged inflammatory response, with elevations in cytokines, chemokines, and markers of endothelial activation. Even when levels are only modestly raised, chronic low-grade inflammation can influence brain function through effects on the blood–brain barrier, microglia, and neurotransmitter systems. Experimental studies in other conditions show that inflammatory signals can induce fatigue, psychomotor slowing, anhedonia, and changes in pain sensitivity—symptoms commonly described in long covid. Inflammation may also alter synaptic plasticity and network connectivity, potentially priming circuits involved in salience detection and threat monitoring, which are likewise implicated in functional neurological symptoms.
Direct and indirect effects on the autonomic nervous system provide another bridge between infection and functional symptomatology. Some individuals develop clear dysautonomia, such as postural tachycardia syndrome or orthostatic hypotension, likely mediated by a combination of immune effects, deconditioning, and possible autoantibodies against autonomic targets. Even where formal criteria are not met, more subtle shifts in autonomic balance toward sympathetic predominance are frequently observed. Chronic sympathetic activation can manifest as palpitations, breathlessness, gastrointestinal disturbance, temperature sensitivity, and sleep disruption. These bodily sensations, when unexpected and poorly understood, can become powerful triggers for anxiety, hypervigilance, and changes in behavior that reinforce illness-focused attention—core processes in functional disorders.
Stress-related neuroendocrine changes interact closely with autonomic and immune pathways. Acute infection occurs against a backdrop of personal, social, and societal stressors, including fear of severe illness, isolation, financial uncertainty, and disruption of normal routines. Activation of the hypothalamic–pituitary–adrenal (HPA) axis and associated cortisol responses is adaptive in the short term, but chronic or dysregulated activation can impair sleep, augment inflammation, and alter hippocampal and prefrontal function. Both blunted and exaggerated cortisol responses have been observed in post-infectious fatigue states, suggesting that different patterns of HPA dysregulation may contribute to vulnerability. In functional neurological conditions, stress-related changes in limbic and prefrontal circuits are thought to influence how bodily signals are interpreted and prioritized, potentially making ambiguous sensations feel threatening and uncontrollable.
Altered interoception—the brain’s processing of internal bodily signals—offers a unifying framework for understanding persistent symptoms across these conditions. During and after infection, individuals experience novel and often intense sensations such as air hunger, chest tightness, palpitations, or unusual pain. The insula, anterior cingulate cortex, and related networks integrate these signals with prior expectations, beliefs, and emotional context to construct a subjective sense of bodily state. If infection and stress heighten the gain on interoceptive pathways, ordinary sensations may be amplified or misclassified as evidence of ongoing damage. Repeated cycles of symptom-focused attention, worry, and behavioral responses such as avoidance or over-rest can further strengthen these predictive models, in keeping with contemporary neurobiological theories of functional neurological symptoms.
Predictive processing accounts emphasize that the brain continually generates expectations about sensory input and updates them based on prediction errors. In the aftermath of a frightening or highly salient illness, expectations about bodily vulnerability and the likelihood of harm can become skewed. For example, after an episode of severe breathlessness with covid, even minor fluctuations in breathing may be interpreted as signs of imminent respiratory failure. This can trigger anxiety and autonomic arousal, which in turn intensify respiratory sensations, reinforcing the original belief. Over time, high-precision expectations about threat can dominate perception, so that the experience of symptoms persists even when objective measures show improvement. Similar mechanisms are proposed in functional motor symptoms, where strong prior beliefs about weakness or loss of control can override intact motor pathways, resulting in genuine disability despite normal structural integrity.
Neuroimaging studies, though still preliminary, provide supportive evidence for network-level changes rather than gross structural damage in many individuals with persistent post-covid symptoms. Alterations have been reported in default mode, salience, and fronto-striatal networks that are involved in attention, self-referential processing, and motor control. Functional neurological disorders are likewise associated with abnormal connectivity between limbic, prefrontal, and sensorimotor regions, including increased influence of emotional and salience networks over motor areas. These overlapping patterns suggest that infection-related immune and stress processes may perturb the same large-scale networks that are central to functional symptom generation, even in the absence of visible lesions.
Microvascular and endothelial dysfunction represent additional biological contributors that intersect with functional mechanisms. SARS-CoV-2 can affect endothelial cells and coagulation pathways, leading in some cases to microthrombi or impaired tissue perfusion. Subtle reductions in cerebral or muscular blood flow may not produce discrete infarcts but can still contribute to exercise intolerance, headache, and cognitive complaints. Individuals may experience pronounced fatigue or “crashes” after relatively minor exertion, prompting concerns about ongoing tissue damage and driving cautious or avoidant behavior. Over time, physical deconditioning, reduced cardiorespiratory fitness, and fear of exacerbation can lower activity thresholds further, mirroring the graded activity limitations observed in functional and chronic fatigue conditions.
Immune-mediated neuropathic processes, including small-fiber neuropathy, have been documented in some patients with persistent post-covid symptoms. These can cause pain, dysesthesias, and autonomic features. However, symptom severity often exceeds what would be expected from objective findings, and neuropathic pain frequently coexists with functional sensory or motor signs. This suggests that peripheral nerve changes may act as an initiating or maintaining factor, with central amplification and functional reorganization contributing to the broader symptom complex. In line with this, chronic pain research shows that peripheral insults can lead to central sensitization, altered cortical representation of the body, and increased attentional capture by pain-related stimuli.
Psychological and social factors do not act independently of biology; they shape and are shaped by the neurobiological processes described above. During the pandemic, high levels of media coverage, uncertainty about prognosis, and variable medical messaging created fertile ground for catastrophic interpretations of ongoing symptoms. People who experienced invalidation, dismissal, or fragmented care may have developed strong beliefs that their condition is mysterious, uncontrollable, and potentially progressive. These beliefs influence patterns of attention and behavior—for example, repeated self-monitoring of heart rate or oxygen saturation, strict avoidance of exertion, or cycles of over-activity followed by enforced rest—that can inadvertently reinforce symptom persistence. Similar dynamics are well recognized in functional neurological disorders, where experiences of trauma, illness, or medical miscommunication can shape expectations about the body and healthcare.
Learned associations also play a key role in symptom perpetuation. If a person repeatedly experiences dizziness or palpitations in specific contexts—such as standing up, being in crowded places, or engaging in cognitively demanding tasks—the brain may begin to predict symptoms whenever those contexts are encountered. These conditioned responses can become automatic and resistant to conscious control, even after the original biological triggers have abated. Motor symptoms can follow similar pathways: an early episode of leg weakness or tremor during acute illness may be followed by recurrent episodes in situations of stress or perceived physical threat. Over time, these patterns can evolve into entrenched functional movement symptoms, maintained by network-level changes in motor control and heightened salience of symptom-related cues.
The experience of “brain fog” illustrates many of these interlocking mechanisms. Inflammation, disrupted sleep, and autonomic changes can directly impair cognitive efficiency and processing speed. At the same time, high levels of self-monitoring (“Will I be able to get through this meeting?”), fear of cognitive failure, and negative predictions about performance can consume limited attentional resources. Functional neuroimaging in analogous conditions shows increased activation of prefrontal control regions during simple tasks, suggesting that individuals may be exerting disproportionate effort to maintain performance. This subjective sense of effort and failure feeds back into beliefs about permanent brain injury, encouraging further withdrawal from cognitive challenges and reinforcing disability.
Importantly, these mechanisms help explain why objective tests may show only mild abnormalities while the lived impact of symptoms is profound. Standard structural imaging and routine electrophysiology are often insensitive to changes in network connectivity, interoceptive processing, or predictive coding. When such tests are reported as “normal,” patients may be told there is “nothing wrong,” which can invalidate their experience and heighten distress. A more nuanced interpretation acknowledges that symptoms arise from real changes in brain–body interaction that are not captured by conventional diagnostics. This perspective aligns with modern understandings of functional neurological disorders as disorders of brain function rather than faked or imagined illness, and it provides a coherent framework for guiding assessment and rehabilitation in people with long covid–related symptoms.
Diagnostic challenges and pitfalls in assessing persistent symptoms
Assessment of persistent symptoms after SARS-CoV-2 infection is complicated by the absence of a single defining biomarker for long covid and the frequent coexistence of functional neurological features. Clinicians must balance the need to exclude serious pathology with the risk of over-investigation and iatrogenic harm. Many people have already undergone extensive testing before they reach specialist services, often with normal or minimally abnormal findings. Repeated imaging, blood tests, and invasive procedures can reinforce the belief that a grave but elusive disease is being missed, heightening anxiety and symptom vigilance. At the same time, prematurely attributing symptoms to stress or “post-viral fatigue” without a careful workup risks overlooking treatable conditions such as myocarditis, thromboembolic disease, autoimmune encephalitis, or significant dysautonomia.
A key challenge is interpreting normal or nonspecific investigations in the context of disabling symptoms. Standard MRI, EEG, and nerve conduction studies frequently show no structural abnormalities, even in individuals reporting severe weakness, sensory loss, or brain fog. Clinicians may be tempted to reassure by saying “everything is normal” or “nothing is wrong,” but patients often hear this as a denial of their experience. The more accurate message is that tests have excluded certain types of damage but do not capture all aspects of brain–body function. Framing results in this way allows room for discussing functional mechanisms without suggesting that symptoms are fabricated. Failure to communicate this nuance is a recurrent pitfall that undermines trust and pushes patients to seek repeated opinions and investigations.
Distinguishing between ongoing organ-specific disease, systemic sequelae of infection, and functional neurological symptoms is rarely straightforward. Symptoms such as palpitations, breathlessness, chest pain, and dizziness may reflect cardiac or pulmonary pathology, dysautonomia, deconditioning, anxiety, or functional disturbance in autonomic regulation—or a combination of these. Similarly, numbness, pain, and weakness might stem from small-fiber neuropathy, inflammatory processes, musculoskeletal problems, or functional motor and sensory changes. An overly categorical approach that forces clinicians to choose a single explanation can miss overlapping contributors. A more fruitful strategy is to ask, for each symptom cluster, what biological, psychological, and social factors are plausibly involved, and how they interact. This formulation-based approach is unfamiliar to many services that are organized around single-organ disease models, and its absence contributes to fragmented and sometimes contradictory opinions.
Another diagnostic pitfall lies in the misapplication of functional neurological disorder criteria. Positive bedside signs such as Hoover’s sign, give-way weakness, inconsistency over time, or symptom modulation with distraction are invaluable for identifying functional components of a presentation. However, they do not exclude concurrent organic pathology, especially in a post-infectious context where microvascular injury, mild neuropathy, or subtle inflammatory changes may also be present. Labeling the entire clinical picture as “functional” simply because some signs meet criteria for functional weakness or tremor can lead to under-recognition of comorbid medical issues and fuel patient fears of being dismissed. Conversely, ignoring clear positive functional signs because symptoms arose after covid, and therefore must be purely organic, can delay access to effective rehabilitation strategies that target learned patterns of movement, attention, and symptom amplification.
Triage decisions early in the course of illness present additional challenges. Many people with persistent symptoms first present to primary care or emergency departments, where time is limited and diagnostic algorithms are geared toward acute, life-threatening conditions. Once serious complications such as pulmonary embolism, myocardial infarction, stroke, or sepsis are ruled out, clinicians may feel uncertain about what to do next. Some respond by arranging large batteries of tests “to be safe,” while others offer vague reassurance without a clear plan for follow-up. Both extremes can be problematic. Over-investigation can entrench illness identity and delay functional recovery, whereas cursory dismissal can damage the therapeutic relationship and increase the likelihood that patients will seek care elsewhere in a more distressed state. Clear pathways for staged assessment, with guidance on which tests are appropriate at different time points and for which symptom profiles, are often lacking.
Temporal fluctuations in symptoms can also mislead clinicians. People with long covid frequently describe good days and bad days, delayed crashes after activity, and unpredictable changes in fatigue, pain, and cognitive function. When assessment happens during a relatively good phase, examination findings may appear entirely normal, encouraging the inference that symptoms are exaggerated. When assessment coincides with a crash, however, patients may appear acutely unwell and distressed, prompting urgent investigations and hospital admission. Without a longitudinal perspective that integrates symptom diaries, collateral histories, and repeat examinations, the clinical picture can seem inconsistent or even contradictory. Misinterpreting fluctuation as evidence against serious illness or, conversely, as proof of episodic organ failure is a common source of diagnostic error.
Psychiatric comorbidity further complicates interpretation. Anxiety, depression, post-traumatic stress, and health-related fear are prevalent among people with persistent post-covid symptoms, whether or not they have identifiable organ damage. Some clinicians, seeing high levels of distress, frame the entire presentation as primary psychiatric illness and focus solely on psychotropic medication or generic counseling. Others, wary of stigma, ignore psychological aspects altogether and pursue an exclusively biomedical workup. Both approaches risk missing the bidirectional interplay between mood, cognition, autonomic regulation, and symptom perception. Functional neurological symptoms are particularly sensitive to this misalignment: if clinicians either over-psychologize or underrecognize the role of stress and trauma, they may fail to provide coherent explanations that integrate mind and body in a way that patients can accept.
Cultural and linguistic factors introduce additional layers of complexity. The language of “long covid,” “post-acute sequelae,” and “functional disorders” carries different meanings across communities and healthcare systems. In some settings, functional diagnoses are routinely equated with malingering or weakness of character, making both patients and clinicians reluctant to use them even when positive clinical signs are present. In others, long covid may be viewed primarily through a biomedical lens that emphasizes viral persistence or irreversible organ damage, leaving little conceptual space for discussing neurobiological models of altered interoception or predictive coding. Misalignment between the explanatory models held by patients, families, and clinicians can manifest as conflict over diagnosis, requests for specific tests, or rejection of referrals to rehabilitation and psychological services.
Communication around uncertainty is a recurring stumbling block. Persistent post-infectious syndromes challenge the traditional medical expectation that every symptom should map neatly onto a discrete diagnosis and a clear structural lesion. In long covid, clinicians often face substantial gaps in evidence and shifting guidelines. Some respond by projecting unwarranted confidence—asserting, for example, that symptoms will certainly resolve within a particular timeframe or that they can only be due to anxiety. Others emphasize uncertainty in a way that feels frightening or unhelpful to patients, suggesting that “we just don’t know what this is” without offering frameworks for understanding and managing symptoms. A more constructive stance involves acknowledging uncertainty while offering provisional formulations, explaining that symptoms are real and can be addressed even as scientific knowledge evolves.
Diagnostic overshadowing is a particular risk for individuals with pre-existing functional neurological symptoms, chronic fatigue, or other contested conditions. When such patients contract covid and subsequently develop new or worsened symptoms, clinicians may attribute all complaints to their prior diagnoses, effectively dismissing the possibility of new pathology. This can delay identification of complications such as hypoxia, myocarditis, or thromboembolism, which may present atypically in people with complex baseline symptomatology. The converse is also true: a strong focus on covid-related mechanisms can overshadow recognition of longstanding functional patterns that predated infection. Comprehensive history-taking that maps symptom trajectories before, during, and after infection is essential to avoid these errors.
Another frequent pitfall is the absence of systematic, function-oriented assessment. Clinical encounters often focus on cataloging symptoms and ruling out emergencies rather than understanding how symptoms affect daily activities, roles, and participation. Without detailed exploration of what the person can and cannot do, on good and bad days, clinicians may underestimate disability or miss patterns suggestive of functional involvement, such as disproportionate symptom escalation with minor exertion, variability across situations, or improvement with distraction. Standardized questionnaires, activity diaries, and structured interviews can provide valuable information on fatigue, cognitive load, sleep, mood, and autonomic symptoms, yet these tools are underused. This lack of functional data contributes to vague, non-committal diagnoses like “post-viral syndrome” that offer little guidance for targeted intervention.
Interpreting autonomic findings requires particular care. Many individuals report symptoms consistent with dysautonomia, and some meet formal criteria for conditions such as postural tachycardia syndrome. Others have borderline or inconsistent abnormalities on tilt-table testing or orthostatic vital signs. Clinicians unfamiliar with the spectrum of normal variation in heart rate and blood pressure may either dismiss these findings as meaningless or overemphasize them as the sole cause of all symptoms. In reality, mild autonomic changes can interact with deconditioning, anxiety, and functional attentional shifts to produce a complex symptom picture. Overly narrow interpretation—treating modest tachycardia as proof of a purely cardiac problem, or regarding normal autonomic tests as ruling out serious symptoms—can misdirect management and fuel patient confusion.
Socioeconomic and access-related factors also shape diagnostic pathways. Individuals with better access to healthcare, private insurance, or specialist networks may undergo extensive, high-technology investigations, increasing the likelihood of incidental findings that muddy the diagnostic waters. Others, especially from marginalized communities, may struggle to obtain even basic follow-up after acute infection, leading to delayed recognition of serious complications and greater reliance on emergency services. For the latter group, labeling symptoms as functional or as long covid without adequate assessment may reinforce existing inequities and mistrust. Recognizing how structural factors influence who gets investigated, how often, and by whom is crucial for interpreting the apparent prevalence and patterns of persistent symptoms.
Service organization can either mitigate or exacerbate diagnostic pitfalls. Fragmented care, in which patients see multiple uncoordinated specialists—neurology, cardiology, pulmonology, psychiatry, rehabilitation—often results in a patchwork of partial diagnoses and conflicting opinions. One clinician may emphasize microvascular injury, another autonomic dysfunction, another depression, and another functional neurological signs. Without a mechanism for integrating these perspectives into a coherent formulation, patients are left to reconcile discrepant narratives on their own. Multidisciplinary assessment models, where clinicians jointly review cases and share a common framework for understanding long covid and functional symptoms, can reduce this fragmentation. However, such models remain the exception rather than the rule, and their absence is a major contributor to ongoing diagnostic confusion and unmet needs.
Evidence-based management strategies and multidisciplinary care
Management of persistent post-covid symptoms with overlapping functional features is most effective when built on a biopsychosocial formulation that is communicated clearly and collaboratively. The initial clinical encounter should prioritize validation of the person’s experience, careful assessment of symptom patterns, and explicit differentiation between ruling out dangerous pathology and addressing the ongoing impact of long covid. Explaining that symptoms are genuine consequences of altered brain–body functioning, even when scans and routine tests are normal, can reduce fear of being dismissed. This framing lays the groundwork for interventions that target specific mechanisms—such as autonomic instability, deconditioning, altered interoception, and maladaptive coping—rather than searching indefinitely for a single structural lesion.
Education and explanation are central therapeutic tools. A coherent narrative that links infection, stress responses, neurobiology, and functional symptoms helps patients understand why they feel unwell and what can reasonably be done. Clinicians can describe the nervous system as having become “sensitized” or “stuck in protection mode,” leading to exaggerated signals of pain, breathlessness, or fatigue. Using metaphors—such as a smoke alarm that goes off too easily or a computer running too many background processes—can make concepts like autonomic dysregulation and predictive processing accessible. Importantly, explanations should emphasize reversibility and the capacity of neural networks to change with practice, while avoiding suggestions that symptoms are imagined or voluntary. Written materials, reputable online resources, and follow-up discussions reinforce this message and allow time for questions.
Goal-setting and collaborative care planning are crucial early steps. Rather than focusing solely on symptom elimination, clinicians can encourage patients to identify valued activities and roles—such as returning to work, caring for family, or resuming hobbies—as concrete targets for intervention. Goals should be specific, realistic, and time-limited, with an emphasis on incremental change. For example, a person who is housebound due to fatigue and dizziness might aim first to tolerate sitting outside for five minutes daily before considering longer walks. Documenting goals and revisiting them regularly helps track progress, adjust strategies, and maintain a sense of agency. Involving family or caregivers in this process can improve support at home and reduce well-intentioned patterns of overprotection that inadvertently reinforce avoidance.
Activity management and pacing strategies occupy a central place in evidence-informed care for long covid–related fatigue, post-exertional symptom exacerbation, and functional symptoms. A structured approach begins with identifying a sustainable baseline of physical and cognitive activity that does not trigger severe delayed crashes. Patients are encouraged to keep diaries of their daily routines, noting types of activities, duration, perceived effort, and subsequent symptom changes. On the basis of this information, clinicians and therapists help the person design a “pacing plan” that distributes exertion more evenly across the day, alternates demanding and lighter tasks, and builds in planned rest before, rather than after, exhaustion. Unlike simplistic graded exercise prescriptions, pacing emphasizes respecting warning signs, prioritizing activities that matter most, and avoiding the boom–bust cycle in which periodic overexertion leads to prolonged setbacks.
For individuals whose symptoms remain stable at a manageable baseline, a cautious, collaborative program of graded increases in activity can be considered. This approach is best supervised by professionals with expertise in post-viral conditions and functional disorders, such as physiotherapists, occupational therapists, or rehabilitation physicians. Increases in activity level should be modest—often 5–10% at a time—and tied to functional goals rather than abstract exercise targets. For example, a patient might progress from walking for five minutes on flat ground three times per week to six minutes every other day, monitoring for delayed symptom flares. If exacerbations occur, the program is adjusted rather than abandoned. Educating patients that temporary setbacks are common and not a sign of permanent harm helps maintain engagement and reduces catastrophic interpretation of symptom fluctuations.
Management of dysautonomia and orthostatic intolerance combines non-pharmacological measures with, when appropriate, targeted medications. Non-pharmacological strategies include increasing fluid and salt intake (where not contraindicated), using compression garments to improve venous return, elevating the head of the bed, and teaching counter-maneuvers such as leg crossing and muscle tensing when lightheadedness occurs. Positional conditioning—gradually increasing time spent upright, moving from lying to sitting to standing to short walks—can improve tolerance over weeks to months. When symptoms are severe or significantly impairing despite these measures, clinicians may consider agents such as beta-blockers, ivabradine, fludrocortisone, or midodrine, guided by specialist assessment and monitoring. Throughout, it is important to frame dysautonomia as a treatable disturbance of autonomic regulation rather than as irreversible cardiovascular damage.
Targeted rehabilitation for functional neurological symptoms is best delivered by teams familiar with contemporary models of these conditions. Physiotherapists and occupational therapists play a central role in retraining movement patterns, reducing maladaptive guarding, and restoring confidence in the body. Interventions often use principles of motor relearning: focusing initially on automatic or unconsciously generated movements, minimizing attention to the affected limb, and using distraction, rhythm, or external cues to facilitate more fluent movement. For example, a patient with functional gait disturbance might practice walking to music or stepping over visual targets, with the therapist gradually reducing supports as control improves. Video feedback, mirror therapy, and dual-task training can help decouple movement from learned associations of weakness or collapse. Gains made in the clinic are consolidated through structured home exercises and graded exposure to feared situations, such as walking in crowded spaces.
Cognitive difficulties, including brain fog, benefit from a blend of compensatory strategies and efforts to improve underlying cognitive efficiency. Speech and language therapists, neuropsychologists, and occupational therapists can teach practical tools such as external memory aids, structured routines, task chunking, and environmental modifications to reduce distraction. Patients are encouraged to schedule cognitively demanding activities at times of day when their energy is highest, to take planned breaks before concentration deteriorates, and to limit multitasking. Where formal assessment reveals specific deficits—for example, in verbal memory or processing speed—tailored exercises can target these domains, although the evidence for cognitive training alone is limited. Education about the effects of fatigue, anxiety, and hypervigilance on cognition helps patients reinterpret lapses as reversible consequences of overload rather than signs of permanent brain damage.
Pain management requires an integrated, multimodal approach. Pharmacological options—including simple analgesics, neuropathic pain agents, and, in select cases, low-dose tricyclics or gabapentinoids—may reduce symptom intensity sufficiently to enable engagement in rehabilitation, but are seldom sufficient on their own. Non-pharmacological interventions such as graded activity, physiotherapy, relaxation training, and cognitive-behavioral strategies for pain coping are essential. Pain neuroscience education, which explains how central sensitization and altered threat processing can amplify pain signals, helps reframe the experience without denying its reality. Techniques such as pacing, activity scheduling, and graded exposure to feared movements support gradual expansion of function, while addressing sleep, mood, and stress further modulates pain perception.
Psychological therapies are not a substitute for medical care but a key component of comprehensive management, particularly when functional mechanisms contribute to symptom persistence. Cognitive-behavioral therapy (CBT) can help patients identify and modify unhelpful beliefs about symptoms—for instance, the conviction that any exertion will cause lasting harm or that brain fog proves irreversible brain injury. Therapists work collaboratively to test these beliefs through behavioral experiments, adjust coping strategies, and address patterns of avoidance, over-monitoring, and all-or-nothing behavior. Other approaches, such as acceptance and commitment therapy, mindfulness-based interventions, and compassion-focused therapy, may support psychological flexibility, reduce shame, and help individuals live in line with values despite ongoing symptoms. For those with trauma histories or significant post-traumatic stress related to hospitalization or severe covid, trauma-focused therapies may be indicated.
Sleep disturbance is common and often perpetuates fatigue, pain, and cognitive difficulties. Management begins with careful assessment of sleep patterns, contributing factors, and potential primary sleep disorders such as obstructive sleep apnea or restless legs, which may require specific treatment. For the majority, non-pharmacological strategies are first-line: stabilizing sleep–wake schedules, reducing stimulant use and screen exposure before bedtime, optimizing the sleep environment, and limiting daytime naps that interfere with nocturnal sleep. CBT for insomnia, delivered individually or in groups, is supported by robust evidence and can be adapted for people with long covid. Short-term use of medication may be considered in select cases, but clinicians should avoid creating dependence on hypnotics or sedating agents that worsen daytime alertness and cognitive function.
Pharmacological management beyond pain and sleep should be individualized and cautious. There is no single drug that treats long covid or functional neurological symptoms as a whole, and polypharmacy can quickly become problematic. When mood or anxiety disorders are present at a clinically significant level, standard treatments—including antidepressants and anxiolytics—can be helpful, but expectations should be realistic: such medications may reduce distress and improve sleep and concentration, thereby indirectly supporting rehabilitation, rather than eliminating all physical symptoms. Stimulant medications or wakefulness promoters have been tried off-label for fatigue and cognitive problems, but evidence is limited and potential side effects must be weighed carefully. Wherever possible, medication changes should be made one at a time, with clear monitoring plans and shared decision-making.
Vocational rehabilitation is an important yet often neglected element of care, given the substantial impact of persistent symptoms on employment. Early discussion of work, including job demands, flexibility of hours, and options for modification, can prevent prolonged absence and loss of role identity. Occupational health teams, employers, and clinicians should collaborate to develop graded return-to-work plans that start with manageable duties at reduced hours and increase gradually as tolerance improves. Adjustments might include remote work, longer breaks, reduced physical demands, or temporary reassignment away from safety-critical tasks. Open communication about fluctuating capacity and the possibility of setbacks helps align expectations. For some individuals, extended sick leave or re-training for less demanding roles may be necessary; in such cases, support with benefits, legal rights, and vocational counseling can reduce financial and psychological strain.
Multidisciplinary care models are well-suited to the complex interplay of physical, cognitive, and emotional factors in long covid with functional features. Core team members typically include primary care providers, specialists (such as pulmonologists, cardiologists, neurologists, or rheumatologists), rehabilitation physicians, physiotherapists, occupational therapists, psychologists, and, where relevant, speech and language therapists or dietitians. Effective teams share a common conceptual framework that integrates biomedical and functional mechanisms, use consistent language when communicating with patients, and coordinate care to avoid duplication and conflicting messages. Multidisciplinary case conferences, joint clinics, and shared electronic records facilitate integrated decision-making. Even where fully staffed clinics are not available, virtual networks and agreed local pathways can approximate multidisciplinary input.
Primary care practitioners remain central coordinators of treatment and follow-up, especially where access to specialist long covid clinics is limited. They can provide continuity, monitor for emerging red flags, and help prioritize referrals to rehabilitation or mental health services. Regular reviews, even brief ones, signal ongoing commitment and allow timely adjustment of management plans. Training and support for primary care teams—in the form of clinical guidelines, decision aids, and access to consultation with specialists experienced in functional neurological disorders—can improve confidence and reduce unnecessary referrals or investigations. Conversely, specialists should communicate clearly back to primary care, outlining specific recommendations, realistic expectations, and indicators for re-referral.
Digital and remote interventions have become increasingly relevant in managing persistent post-covid symptoms, particularly given geographic and access barriers. Telehealth can support follow-up consultations, group education sessions, and delivery of psychological therapies. Online self-management programs that include modules on pacing, dysautonomia, sleep hygiene, and coping with brain fog can extend the reach of limited specialist services. However, digital approaches must be designed with attention to accessibility: for individuals with severe fatigue, cognitive overload, or sensory sensitivity, brief, well-structured content with options for pauses and repetition is preferable to dense, text-heavy platforms. Where possible, remote tools should complement rather than replace opportunities for in-person assessment and rehabilitation, particularly for those with complex functional motor symptoms.
Family and social support can significantly influence outcomes. Involving close contacts in education sessions helps them understand the nature of the condition, the rationale for pacing and graded re-engagement, and the importance of encouraging autonomy without pressuring the person to “just push through.” Families can assist with implementing routines, monitoring progress, and celebrating small gains, while also being mindful of their own stress and potential caregiver burden. Social prescribing—linking individuals to community resources such as peer support groups, gentle physical activity programs, or creative activities—can help rebuild social networks and identity beyond the patient role. For some, practical assistance with housing, finances, or caregiving responsibilities is essential to create the stability needed for rehabilitation to proceed.
Peer support and patient-led groups have played a prominent role in the long covid landscape, offering validation, shared strategies, and advocacy. Clinicians can acknowledge the value of such networks while helping patients navigate the variability in quality and tone of information shared online. Encouraging engagement with balanced, evidence-informed communities, and discussing how to handle alarming or absolutist narratives, can harness the benefits of peer support without amplifying fear or fatalism. In some services, trained peer mentors with lived experience of recovery from long covid or functional neurological symptoms work alongside professionals, providing a unique perspective on pacing, setbacks, and the emotional challenges of rehabilitation.
Outcome monitoring and iterative adjustment of the care plan are essential components of evidence-based management. Standardized measures of fatigue, pain, mood, autonomic symptoms, and functional capacity—such as questionnaires and simple performance tests—can be administered at baseline and regular intervals. These data provide feedback on which interventions are helping, where progress has plateaued, and which domains require additional attention. Discussing results with patients reinforces a shared sense of purpose and may highlight improvements that are not immediately apparent in day-to-day experience, such as increased walking distance or reduced recovery time after exertion. When progress is limited, reassessment of the formulation, exploration of barriers to engagement, and consideration of comorbidities or unaddressed psychosocial factors can guide refinement of the approach.
Iatrogenic harm and over-medicalization are ongoing risks in this field, making it important for clinicians to critically appraise interventions and avoid unproven or high-cost treatments that promise cures without robust evidence. Patients and families may encounter commercial offerings such as experimental antiviral regimens, unregulated immune-modulating therapies, or expensive diagnostic panels purporting to identify occult infections or toxic exposures. While understandable in the context of distress and uncertainty, pursuing such avenues can divert time, energy, and resources from approaches with a stronger evidence base, and occasionally cause direct harm. A transparent, empathic discussion about the current limits of knowledge, the rationale for recommended therapies, and the importance of weighing risks and benefits helps support informed decision-making.
Across all aspects of care, consistent messaging that symptoms are real, that improvement is possible even when tests are normal, and that progress often occurs in small, non-linear steps is fundamental. Management of long covid with functional neurological features is typically a marathon rather than a sprint; it requires patience, flexibility, and collaboration from patients, clinicians, and wider support systems. By combining clear explanation, tailored rehabilitation, attention to mood and sleep, and coordinated multidisciplinary input, services can help individuals rebuild function, regain confidence, and move toward a life that is less dominated by illness, even in the absence of a single curative treatment.
Implications for research, public health, and patient advocacy
The intersection of long covid and functional neurological symptoms highlights significant gaps in existing research paradigms. Traditional biomedical models prioritizing discrete disease entities and structural lesions are poorly equipped to capture disorders of brain–body interaction, altered interoception, and network-level dysfunction. Future studies need to integrate immunology, autonomic physiology, neuroimaging, and computational neuroscience with rigorous assessment of psychological, social, and contextual variables. Longitudinal cohort designs that track individuals from acute infection through recovery or chronicity, with repeated multimodal measurements, are particularly important for delineating trajectories, identifying predictors of persistent symptoms, and distinguishing self-limiting post-viral states from more entrenched syndromes that resemble functional neurological disorders.
Standardization of definitions and outcome measures is a crucial research priority. Variability in how long covid is defined—by symptom duration, test confirmation of infection, or specific symptom clusters—has hampered synthesis of findings across studies. Similarly, functional neurological symptoms are often under-recognized or coded inconsistently, limiting the ability to examine their prevalence and impact within long covid cohorts. Developing and adopting consensus criteria that acknowledge overlap between organic and functional mechanisms would allow more accurate stratification of participants. Core outcome sets should include not only biomarkers and organ-specific metrics but also measures of fatigue, pain, cognitive function, autonomic symptoms, daily functioning, quality of life, and health-related anxiety, enabling comparison across interventions and settings.
Mechanistic research needs to move beyond a search for a single unifying cause toward models that accommodate heterogeneity and multiple interacting pathways. Subgrouping based on clinical phenotypes—for example, dysautonomia-dominant, fatigue-dominant, pain-dominant, or cognitive-dominant presentations—may reveal different constellations of immune markers, autonomic profiles, sleep disturbance, and network connectivity. Within each subgroup, careful assessment for functional neurological signs and patterns of symptom amplification can clarify how neurobiological vulnerability interacts with expectations, attention, and learning. Advanced analytic approaches, such as machine learning applied to large, well-characterized datasets, may help identify latent clusters and prognostic profiles, but these methods require transparent, reproducible pipelines and external validation to avoid overfitting and spurious conclusions.
Clinical trials must be designed to reflect the complexity of persistent post-covid symptoms and the likelihood that multimodal interventions will be required. Single-modality approaches that test a single drug or therapy in unselected populations are unlikely to yield large effect sizes. Instead, adaptive trial designs and pragmatic comparative-effectiveness studies that combine pharmacological treatments with rehabilitation, psychological interventions, and self-management support may provide more clinically relevant information. Stratified randomization based on baseline characteristics—such as presence of dysautonomia, severity of brain fog, or evidence of ongoing inflammation—can help identify which subgroups benefit most from particular components. Measurement of both short-term symptom change and longer-term functional outcomes, including return to work and social participation, should be prioritized.
Ethical considerations in research on long covid and functional neurological symptoms are substantial. Many individuals have experienced prior dismissal or conflicting explanations; recruitment into studies that reiterate narrow or stigmatizing narratives risks further harm. Involving patients in study design, consent processes, and communication of results can help ensure that research questions are meaningful and that language used in protocols and publications respects lived experience. Care must be taken to avoid framing functional explanations as implying that symptoms are “all in the mind” or voluntary; instead, research outputs should consistently convey that these are disorders of nervous system function with real, measurable correlates, even when conventional imaging is normal. Transparency about uncertainty and limitations of current knowledge is essential to maintain trust.
From a public health perspective, the burden of long covid with overlapping functional symptoms extends far beyond specialist clinics. Persistent fatigue, pain, and cognitive difficulties affect workforce participation, educational attainment, caregiving capacity, and social cohesion. Health systems must plan for sustained demand on primary care, rehabilitation, and mental health services, recognizing that needs are likely to persist for years rather than months. Population-level surveillance that includes functional outcome measures—not only hospitalizations and mortality—is required to estimate the true impact and to inform resource allocation. Integration of long covid modules into existing health surveys and registries can provide data on prevalence, risk factors, and disparities across sociodemographic groups.
Health inequities are a central concern. Evidence to date suggests that long covid disproportionately affects individuals from socioeconomically disadvantaged backgrounds, racialized communities, and those in precarious or public-facing employment. These same groups often have limited access to comprehensive assessment, specialist services, or workplace accommodations. Public health responses must therefore include targeted outreach, culturally adapted information, and low-barrier pathways to rehabilitation and support. Policies that protect employment, provide sick leave, and ensure access to disability benefits when needed are critical to preventing downward spirals of financial hardship, housing instability, and worsening health. Without explicit attention to equity, long covid and associated functional symptoms risk amplifying existing social and health disparities.
Communication strategies at the population level require careful balancing of validation, realism, and hope. Messaging that overemphasizes catastrophic or irreversible outcomes can fuel anxiety, hypervigilance, and symptom amplification, whereas minimizing or dismissing persistent symptoms undermines trust and discourages help-seeking. Public health agencies, professional bodies, and patient organizations should collaborate to develop clear, consistent materials explaining what is known about long covid, including the role of neuroimmune changes, dysautonomia, and functional nervous system dysregulation. Emphasizing that many people improve over time, that rehabilitation can enhance recovery even when tests are normal, and that psychological support is a legitimate component of care—not an implication that symptoms are imaginary—can shape more constructive public narratives.
Education and training of healthcare professionals constitute a major public health priority. Many clinicians have had minimal exposure to contemporary models of functional neurological disorders, predictive processing, or interoceptive dysregulation. Without this foundation, they may default to outdated dichotomies between “organic” and “psychological” illness, contributing to fragmented care and patient mistrust. Continuing professional development programs, clinical guidelines, and interdisciplinary workshops should explicitly address the overlap between long covid and functional symptoms, provide practical tools for assessment and explanation, and model language that is validating yet scientifically grounded. Embedding such training in medical, nursing, and allied health curricula will help create a workforce better equipped to manage current and future post-infectious syndromes.
Service design and commissioning decisions must reflect the need for integrated, multidisciplinary pathways. Standalone long covid clinics that focus narrowly on cardiopulmonary sequelae risk overlooking functional neurological presentations and complex psychosocial needs. Conversely, mental health or rehabilitation services working in isolation may lack the capacity to investigate and manage residual organ damage or immune-mediated complications. Public health planners should support models that bring together expertise from internal medicine, neurology, psychiatry, psychology, physiotherapy, occupational therapy, and social work, with clear criteria for referral and mechanisms for shared care. Telehealth networks, regional hubs with outreach to primary care, and stepped-care models that triage based on severity and complexity can increase reach while making efficient use of scarce specialist resources.
Patient advocacy has been a driving force in bringing long covid to public attention and securing resources for research and care. Individuals and groups with lived experience have documented symptom patterns, highlighted service gaps, and challenged narratives that minimized or psychologized their suffering. As the field matures, partnerships between advocacy organizations, clinicians, and researchers will be essential for co-producing guidelines, educational materials, and research priorities. Such collaborations can help ensure that functional explanations are presented in ways that resonate with patients’ experiences and that interventions are acceptable, feasible, and culturally sensitive. Involving advocates in policy discussions at local, national, and international levels can keep the needs of people with persistent symptoms visible amid shifting political and healthcare agendas.
At the same time, the advocacy landscape is heterogeneous, with a spectrum of views on mechanisms and treatment approaches. Some groups emphasize viral persistence or specific biomedical hypotheses to the exclusion of functional or psychosocial factors, while others are more open to integrated frameworks that encompass both. Constructive dialogue between different advocacy communities and clinicians can help bridge these divides, reduce polarization, and avoid creating false binaries between “biological” and “psychological” camps. Research funders and policymakers should recognize this diversity and support platforms where stakeholders can negotiate common ground, articulate shared goals—such as better access to assessment, rehabilitation, and financial support—and respectfully debate areas of disagreement.
Public narratives around effort, resilience, and illness also warrant attention from policymakers and advocates. People with persistent post-covid symptoms often encounter skepticism rooted in cultural ideals of productivity and self-reliance. Framing long covid and functional neurological symptoms as failures of willpower or as conditions that can be overcome solely through determination undermines the legitimacy of sufferers’ experiences and discourages them from seeking appropriate care. Public campaigns that highlight stories of gradual recovery, emphasize the role of structured support and rehabilitation, and normalize the need for accommodations at work and school can counteract stigmatizing narratives. Collaboration with employers, unions, educational institutions, and insurers is crucial to embed these perspectives in organizational policies and practices.
Global health considerations extend beyond high-income settings. Many low- and middle-income countries face high burdens of covid-19 with limited capacity for specialized assessment or long-term follow-up. In these contexts, scalable, low-cost interventions—such as brief psychoeducational programs, community-based rehabilitation, and task-shifted psychological support delivered by non-specialists—may be the most feasible options. Research on long covid and functional neurological symptoms must therefore include diverse populations and settings, rather than focusing solely on tertiary centers in wealthier countries. International collaborations, open-access training materials, and shared data resources can accelerate knowledge transfer and adapt evidence-based strategies to different health system constraints.
Sustained investment in this field should be framed not only as a response to a single virus but as preparation for future pandemics and post-infectious syndromes. Lessons learned about integrating biological and functional models, building flexible rehabilitation services, and engaging patient communities can inform broader strategies for managing chronic, multisystem conditions that straddle traditional specialty boundaries. Public health agencies and research funders have an opportunity to use the momentum generated by long covid advocacy to modernize approaches to medically complex, often stigmatized conditions, ensuring that future patients do not face the same degree of uncertainty, fragmentation, and invalidation that many have experienced during this pandemic.
